Anne M. Denham, PharmD
Articles
February 26th 2014
Positive Predictive Values of ICD-9 Codes to Identify Patients With Stroke or TIA
Kari L. Olson, BSc(Pharm), PharmD Michele D. Wood, PharmD Thomas Delate, PhD Lisa J. Lash, PharmD Jon Rasmussen, PharmD Anne M. Denham, PharmD John A. Merenich, MD
This study determined that ICD-9 codes 433.X1, 434.XX, and V12.54 had positive predictive values >90%, and may be used to focus care on stroke patients.
October 1st 2007
Angiotensin-converting Enzyme Inhibitor Therapy for Coronary Artery Disease and Diabetes Mellitus
Karen J. McConnell, PharmD Emily B. Zadvorny, PharmD Anne M. Denham, PharmD Sheila L. Kasten, PharmD Kara A. Hutka, PharmD Cedar R. Koetting, PharmD John A. Merenich, MD for the Clinical Pharmacy Cardiac Risk Service Study Group
Latest Updated Articles
Published: May 9th 2024 | Updated: May 21st 2024
FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors
Published: September 3rd 2024 | Updated: September 10th 2024
PCOC 2024 Promises to Hit All the High Notes
Published: August 30th 2024 | Updated: September 10th 2024
Symptom-Triggered Testing Detects Early-Stage Ovarian Cancer in 1 in 4 Women
Published: August 31st 2024 | Updated: September 10th 2024
Low Patient Involvement in First-Line Ovarian Cancer Treatment Decisions in Europe, US
Published: August 28th 2024 | Updated: September 10th 2024
Illuminating the Future: Dr Kristen Whitney on What's Next for Dermoscopy
Published: August 4th 2024 | Updated: September 10th 2024
Who Should Have Lp(a) Levels Tested? Experts Take Sides
